Investigations of the anti-inflammatory effects of vitamin D in adipose tissue: Results from an in vitro study and a randomized controlled trial

Hormone and Metabolic Research

Volumn 45, Issue 6, 2013, Pages 456-462

  Wamberg, L ^a   Cullberg, K B ^a   Rejnmark, L ^a   Richelsen, B ^a   Pedersen, S B ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

adiponectin; calcitriol; cytokines; obesity

Indexed keywords

CALCITRIOL; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; VITAMIN D;

ADIPOSE TISSUE; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL;

ADIPOSE TISSUE; ADULT; ANTI-INFLAMMATORY AGENTS; FEMALE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; OBESITY; VITAMIN D;

EID: 84878541449     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1331746     Document Type: Article

References (53)

1. Forouhi N. G., Luan J., Cooper A., Boucher B. J., Wareham N. J. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes: 2008; 57 2619 2625
2. Kayaniyil S., Vieth R., Retnakaran R., Knight J. A., Qi Y., Gerstein H. C., Perkins B. A., Harris S. B., Zinman B., Hanley A. J. Association of Vitamin D With Insulin Resistance and β-Cell Dysfunction in Subjects at Risk for Type 2 Diabetes. Diabetes Care: 2010; 33 1379 1381
3. Botella-Carretero J. I., Alvarez-Blasco F., Villafruela J. J., Balsa J. A., Vazquez C., Escobar-Morreale H. F. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr: 2007; 26 573 580
4. Ford E. S., Ajani U. A., McGuire L. C., Liu S. Concentrations of Serum Vitamin D and the Metabolic Syndrome Among U.S. Adults. Diabetes Care: 2005; 28 1228 1230
5. Scragg R., Sowers M., Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care: 2004; 27 2813 2818
6. Wang T. J., Pencina M. J., Booth S. L., Jacques P. F., Ingelsson E., Lanier K., Benjamin E. J., D'Agostino R. B., Wolf M., Vasan R. S. Vitamin D deficiency and risk of cardiovascular disease. Circulation: 2008; 117 503 511
7. White J. H. Regulation of intracrine production of 1,25-dihydroxyvitamin D and its role in innate immune defense against infection. Arch Biochem Biophys: 2012; 523 58 63
8. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L., Ferrante A. W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest: 2003; 112 1796 1808
9. Xu H., Barnes G. T., Yang Q., Tan G., Yang D., Chou C. J., Sole J., Nichols A., Ross J. S., Tartaglia L. A., Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest: 2003; 112 1821 1830
10. Berg A. H., Scherer P. E. Adipose tissue, inflammation, and cardiovascular disease. Circ Res: 2005; 96 939 949
11. Feve B., Bastard J-P. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol: 2009; 5 305 311
12. Bruun J. M., Pedersen S. B., Richelsen B. Regulation of Interleukin 8 Production and Gene Expression in Human Adipose Tissue in Vitro. J Clin Endocrinol Metab: 2001; 86 1267 1273
13. Olholm J., Paulsen S. K., Cullberg K. B., Richelsen B., Pedersen S. B. Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants. Int J Obes (Lond): 2010; 34 1546 1553
14. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., Kitazawa S., Miyachi H., Maeda S., Egashira K., Kasuga M. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest: 2006; 116 1494 1505
15. Kamei N., Tobe K., Suzuki R., Ohsugi M., Watanabe T., Kubota N., Ohtsuka-Kowatari N., Kumagai K., Sakamoto K., Kobayashi M., Yamauchi T., Ueki K., Oishi Y., Nishimura S., Manabe I., Hashimoto H., Ohnishi Y., Ogata H., Tokuyama K., Tsunoda M., Ide T., Murakami K., Nagai R., Kadowaki T. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem: 2006; 281 26602 26614
16. Christiansen T., Richelsen B., Bruun J. M. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes: 2005; 29 146 150
17. Bruun J., Verdich C., Toubro S., Astrup A., Richelsen B. Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur J Endocrinol: 2003; 148 535 542
18. Kern P. A., Ranganathan S., Li C., Wood L., Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. AJP - Endocrinol Metab: 2001; 280 E745 E751
19. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J- i., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y. Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity. Biochem Biophys Res Commun: 1999; 257 79 83
20. Lihn A. S., Pedersen S. B., Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev: 2005; 6 13 21
21. Trujillo M. E., Scherer P. E. Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med: 2005; 257 167 175
22. Lihn A. S., Bruun J. M., He G., Pedersen S. B., Jensen P. F., Richelsen B. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol: 2004; 219 9 15
23. Holick M. F. Vitamin D Deficiency. N Engl J Med: 2007; 357 266 281
24. Haussler M. R., Whitfield G. K., Haussler C. A., Hsieh J. C., Thompson P. D., Selznick S. H., Dominguez C. E., Jurutka P. W. The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J Bone Miner Res: 1998; 13 325 349
25. Zhang Z., Yuan W., Sun L., Szeto F. L., Wong K. E., Li X., Kong J., Li Y. C. 1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells. Kidney Int: 2007; 72 193 201
26. Zhang Y., Leung DY M., Richers B. N., Liu Y., Remigio L. K., Riches D. W., Goleva E. Vitamin D Inhibits Monocyte/Macrophage Proinflammatory Cytokine Production by Targeting MAPK Phosphatase-1. J Immunol: 2012; 188 2127 2135
27. Eleftheriadis T., Antoniadi G., Liakopoulos V., Kartsios C., Stefanidis I., Galaktidou G. Paricalcitol reduces basal and lipopolysaccharide-induced (LPS) TNF-α and IL-8 production by human peripheral blood mononuclear cells. Int Urol Nephrol: 2010; 42 181 185
28. Giulietti A., van Etten E., Overbergh L., Stoffels K., Bouillon R., Mathieu C. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract: 2007; 77 47 57
29. Cohen M. L., Douvdevani A., Chaimovitz C., Shany S. Regulation of TNF-alpha by 1alpha,25-dihydroxyvitamin D3 in human macrophages from CAPD patients. Kidney Int: 2001; 59 69 75
30. Bao B. Y., Yao J., Lee Y. F. 1à 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis. Carcinogenesis: 2006; 27 1883 1893
31. Nonn L., Peng L., Feldman D., Peehl D. M. Inhibition of p38 by Vitamin D Reduces Interleukin-6 Production in Normal Prostate Cells via Mitogen-Activated Protein Kinase Phosphatase 5: Implications for Prostate Cancer Prevention by Vitamin D. Cancer Res: 2006; 66 4516 4524
32. Lorente-Cebrian S., Eriksson A., Dunlop T., Mejhert N., Dahlman I., Astrom G., Sjolin E., Wahlen K., Carlberg C., Laurencikiene J., Heden P., Arner P., Ryden M. Differential effects of 1alpha,25-dihydroxycholecalciferol on MCP-1 and adiponectin production in human white adipocytes. Eur J Nutr: 2012; 51 335 342
33. Wamberg L., Richelsen B., Pedersen S. B., Rejnmark L. The effect of high-dose vitamin D supplementation on calcitropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxy-vitamin D - results from a randomized controlled study. Calcif Tissue Int: 2012; Submitted
34. Wellen K. E., Hotamisligil G. S. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest: 2003; 112 1785 1788
35. Hotamisligil G. S. Inflammation and metabolic disorders. Nature: 2006; 444 860 867
36. Despres J. P., Lemieux I. Abdominal obesity and metabolic syndrome. Nature: 2006; 444 881 887
37. Hotamisligil G. S., Shargill N. S., Spiegelman B. M. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance. Science: 1993; 259 87 91
38. Bruun J. M., Lihn A. S., Pedersen S. B., Richelsen Br. Monocyte Chemoattractant Protein-1 Release Is Higher in Visceral than Subcutaneous Human Adipose Tissue (AT): Implication of Macrophages Resident in the AT. J Clin Endocrinol Metab: 2005; 90 2282 2289
39. Gonzalez-Gay M. A., De Matias J. M., Gonzalez-Juanatey C., Garcia-Porrua C., Sanchez-Andrade A., Martin J., Llorca J. Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol: 2006; 24 83 86
40. Rostkowska-Nadolska B., Sliupkas-Dyrda E., Potyka J., Kusmierz D., Fraczek M., Krecicki T., Kubik P., Zatonski M., Latocha M. Vitamin D derivatives: calcitriol and tacalcitol inhibits interleukin-6 and interleukin-8 expression in human nasal polyp fibroblast cultures. Adv Med Sci: 2010; 55 86 92
41. Lira F., Rosa J., Cunha C., Ribeiro E., Oller do Nascimento C., Oyama L., Mota J. Supplementing alpha-tocopherol (vitamin E) and vitamin D3 in high fat diet decrease IL-6 production in murine epididymal adipose tissue and 3T3-L1 adipocytes following LPS stimulation. Lipids Health Dis: 2011; 10 37
42. Wamberg L., Christiansen T., Paulsen S. K., Fisker S., Rask P., Rejnmark L., Richelsen B., Pedersen S. B. Expression of vitamin D-metabolizing enzymes in human adipose tissue - the effect of obesity and diet-induced weight loss. Int J Obes: 2012; 10.1038/ijo.2012.112
43. Matilainen J. M., Husso T., Toropainen S., Seuter S., Turunen M. P., Gynther P., Yla-Herttuala S., Carlberg C., Vaisanen S. Primary effect of 1alpha,25(OH)D on IL-10 expression in monocytes is short-term down-regulation. Biochim Biophys Acta: 2010; 1803 1276 1286
44. Lee B. N., Kim T. H., Jun J. B., Yoo D. H., Woo J. H., Choi S. J., Lee Y. H., Song G. G., Kim Y., Lee J. Y., Sohn J., Ji J. D. Upregulation of interleukin-1beta production by 1,25-dihydroxyvitamin D(3) in activated human macrophages. Mol Biol Rep: 2011; 38 2193 2201
45. Fox C. S., Massaro J. M., Hoffmann U., Pou K. M., Maurovich-Horvat P., Liu C. Y., Vasan R. S., Murabito J. M., Meigs J. B., Cupples L. A., D'Agostino R. B. Sr, O'Donnell C. J. Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study. Circulation: 2007; 116 39 48
46. Pittas A. G., Harris S. S., Stark P. C., Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care: 2007; 30 980 986
47. Jorde R., Sneve M., Torjesen P. A., Figenschau Y., Goransson L. G., Omdal R. No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine: 2010; 50 175 180
48. Zittermann A., Frisch S., Berthold H. K., Gotting C., Kuhn J., Kleesiek K., Stehle P., Koertke H., Koerfer R. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr: 2009; 89 1321 1327
49. Holick M. F., Binkley N. C., Bischoff-Ferrari H. A., Gordon C. M., Hanley D. A., Heaney R. P., Murad M. H., Weaver C. M. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab: 2011; 96 1911 1930
50. Lagunova Z., Porojnicu A. C., Vieth R., Lindberg F. A., Hexeberg S., Moan J. Serum 25-Hydroxyvitamin D Is a Predictor of Serum 1,25-Dihydroxyvitamin D in Overweight and Obese Patients. J Nutr: 2011; 141 112 117
51. Zehnder D., Bland R., Williams M. C., McNinch R. W., Howie A. J., Stewart P. M., Hewison M. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab: 2001; 86 888 894
52. Ching S., Kashinkunti S., Niehaus M. D., Zinser G. M. Mammary adipocytes bioactivate 25-hydroxyvitamin D3 and signal via vitamin D3 receptor, modulating mammary epithelial cell growth. J Cell Biochem: 2011; 112 3393 3405
53. Li J., Byrne M. E., Chang E., Jiang Y., Donkin S. S., Buhman K. K., Burgess J. R., Teegarden D. 1alpha,25-Dihydroxyvitamin D hydroxylase in adipocytes. J Steroid Biochem Mol Biol: 2008; 112 122 126